Diabetes · Tablet
sitagliptin · 100 mg
Januvia is an oral diabetes medicine that helps control blood sugar levels. It is used in adults with type 2 diabetes, often together with diet and exercise. The medication works by increasing incretin levels to stimulate insulin release after meals. Patients must follow the prescribed regimen and monitoring plan.
Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that increases and prolongs the action of incretin hormones, which stimulate insulin release in response to meals.
Adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes.
100 mg once daily, with or without food. Adjust in renal impairment.
Monitor for pancreatitis. Rare cases of severe joint pain and bullous pemphigoid reported.
Renal dosing required for moderate to severe impairment.
No clinically meaningful interactions with metformin or sulfonylureas.
Store at room temperature, 20-25°C.
This product information is provided for educational purposes only and is not a substitute for professional medical advice.
